Ligand · 9AO
9AO · N~2~-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-N~5~-(N'-{[2-(propanoylamino) ethyl]carbamoyl}carbamimidoyl)-D-ornithinamide
9AO, N~2~-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-N~5~-(N'-{[2-(propanoylamino) ethyl]carbamoyl}carbamimidoyl)-D-ornithinamide (C33 H41 N7 O5, 615.7 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every…
- Component
- 9AO
- Formula
- C33 H41 N7 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
9AO in 1 structure; the first of them:
- 5ZBQ · The crystal structure of human neuropeptide Y Y1 receptor with ur- MK299 · 9AO A1301 · binds LEU26, PRO117, GLN120, CYS121, ILE124, PHE173, ASP200, THR212 and 12 more
Residues it binds most
PHE 1, LEU 1, THR 1, ASP 1, GLN 1, HIS 1, ASN 1, CYS 1, ILE 1, PRO 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.